Mitapivat in adult patients with pyruvate kinase deficiency receiving regular transfusions (ACTIVATE-T): a multicentre, open-label, single-arm, phase 3 trial.
Lancet Haematol
; 9(10): e724-e732, 2022 Oct.
Article
in En
| MEDLINE
| ID: mdl-35988546
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pyruvate Kinase
/
Hemoglobins
Type of study:
Clinical_trials
Limits:
Adolescent
/
Adult
/
Female
/
Humans
/
Male
Language:
En
Journal:
Lancet Haematol
Year:
2022
Document type:
Article
Country of publication:
Reino Unido